Quadrant Capital Group LLC Glaukos Corp Transaction History

Quadrant Capital Group LLC

$2.65 Billion
Q1 2025

A detailed history of Quadrant Capital Group LLC transactions in Glaukos Corp stock. As of the latest transaction made, Quadrant Capital Group LLC holds 6,331 shares of GKOS stock, worth $634,049. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,331

Previous 2,300 175.26%

Holding current value

$634,049

Previous $344,000 81.1%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$96.6 - $161.22 $389,394 - $649,877	4,031 Added 175.26%	6,331 $623,000
Q4 2024 Feb 12, 2025	BUY	$126.42 - $152.67 $9,228 - $11,144	73 Added 3.28%	2,300 $344,000
Q3 2024 Nov 12, 2024	BUY	$113.62 - $135.39 $35,108 - $41,835	309 Added 16.11%	2,227 $290,000
Q2 2024 Aug 12, 2024	BUY	$89.48 - $118.35 $51,629 - $68,287	577 Added 43.03%	1,918 $226,000
Q1 2024 May 15, 2024	BUY	$76.4 - $96.33 $31,476 - $39,687	412 Added 44.35%	1,341 $126,000
Q4 2023 Feb 08, 2024	BUY	$59.53 - $85.11 $19,585 - $28,001	329 Added 54.83%	929 $73,000
Q3 2023 Nov 14, 2023	BUY	$69.23 - $79.09 $13,153 - $15,027	190 Added 46.34%	600 $45,000
Q2 2023 Aug 09, 2023	BUY	$45.44 - $71.21 $3,226 - $5,055	71 Added 20.94%	410 $29,000
Q1 2023 May 11, 2023	BUY	$43.88 - $52.48 $5,572 - $6,664	127 Added 59.91%	339 $16,000
Q4 2022 Feb 10, 2023	SELL	$40.82 - $57.75 $32,615 - $46,142	-799 Reduced 79.03%	212 $9,000
Q3 2022 Nov 10, 2022	BUY	$46.84 - $58.49 $34,286 - $42,814	732 Added 262.37%	1,011 $54,000
Q2 2022 Aug 09, 2022	BUY	$34.86 - $63.77 $7,564 - $13,838	217 Added 350.0%	279 $13,000
Q1 2022 May 06, 2022	BUY	$44.33 - $57.82 $398 - $520	9 Added 16.98%	62 $4,000
Q4 2021 Feb 01, 2022	SELL	$40.27 - $56.99 $6,684 - $9,460	-166 Reduced 75.8%	53 $2,000
Q3 2021 Nov 12, 2021	BUY	$47.43 - $84.23 $9,580 - $17,014	202 Added 1188.24%	219 $11,000
Q2 2020 Aug 13, 2020	BUY	$28.78 - $46.83 $489 - $796	17 New	17 $1,000
Q4 2019 Feb 03, 2020	SELL	$54.18 - $65.64 $18,096 - $21,923	-334 Closed	0 $0
Q3 2019 Oct 24, 2019	BUY	$58.58 - $83.91 $19,565 - $28,025	334 New	334 $20,000

Others Institutions Holding GKOS

# of Institutions

358

Shares Held

50.2M

Call Options Held

260K

Put Options Held

776K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.77B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Glaukos Corp Transaction History